Please login to the form below

Not currently logged in
Email:
Password:

ERS meeting

This page shows the latest ERS meeting news and features for those working in and with pharma, biotech and healthcare.

GSK and Novartis lead at PM Society Digital Awards

GSK and Novartis lead at PM Society Digital Awards

GSK’s My PAH mobile app by the EarthWorks and its ERS meeting by ebee Health were rewarded, as were Novartis’COPD life is calling by Health Unlimited and the HACk – ... ERS - GSK respiratory by ebee Health. Multichannel campaign. PRIME – Making

Latest news

  • GSK sees COPD future in triple therapy GSK sees COPD future in triple therapy

    One set back for the triple therapies came last year, however, when a study reported at the European Respiratory Society ERS) meeting found that removing the steroid component from a triple

  • Questions raised about affordability of asthma antibodies Questions raised about affordability of asthma antibodies

    Questions raised about affordability of asthma antibodies. Positive data on GSK and Teva anti-IL-5 candidates at ERS congress highlights cost concerns. ... GlaxoSmithKline (GSK) and Teva presented positive phase III trials of their respective anti-IL-5

  • Novartis showcases COPD candidates at ERS meeting Novartis showcases COPD candidates at ERS meeting

    Novartis showcases COPD candidates at ERS meeting. Positive results for three late-stage drugs. ... Novartis raised a challenge to its competitors in the chronic obstructive pulmonary disease (COPD) sector at the European Respiratory Society meeting this

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics